Microbiome Therapeutics Market Revenue 2024 to 2034
Microbiome Therapeutics Market Revenue 2024 to 2034
The Microbiome Therapeutics Market is set to surge from USD 3.46 Bn in 2024 to USD 30.34 Bn by 2034, registering a remarkable CAGR of 24.2%.
Report ID: 10294
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 3.46 Bn
Forecast Year,
USD USD 30.34 Bn
CAGR, 2025 -
24.2%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Microbiome Therapeutics Market Size Analysis
Microbiome Therapeutics Market Size By Therapy Type 2024 to 2034 (USD )
| Therapy Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Live Biotherapeutic Products | 1.59 | 1.99 | 2.47 | 3.07 | 3.82 | 4.74 | 5.89 | 7.36 | 9.18 | 11.37 | 14.10 |
| FMT/Consortia | 0.97 | 1.20 | 1.48 | 1.83 | 2.28 | 2.84 | 3.54 | 4.37 | 5.43 | 6.75 | 8.41 |
| Microbiome Modulators | 0.62 | 0.77 | 0.96 | 1.20 | 1.49 | 1.85 | 2.28 | 2.82 | 3.48 | 4.35 | 5.42 |
| Others | 0.28 | 0.34 | 0.43 | 0.53 | 0.66 | 0.82 | 1.02 | 1.27 | 1.57 | 1.95 | 2.42 |
Microbiome Therapeutics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C. difficile | 0.90 | 1.12 | 1.39 | 1.73 | 2.15 | 2.68 | 3.33 | 4.14 | 5.16 | 6.41 | 8.00 |
| IBD | 0.83 | 1.04 | 1.29 | 1.60 | 1.99 | 2.48 | 3.08 | 3.82 | 4.77 | 5.97 | 7.40 |
| IBS | 0.42 | 0.52 | 0.64 | 0.79 | 0.99 | 1.22 | 1.52 | 1.90 | 2.33 | 2.91 | 3.60 |
| Metabolic/Obesity | 0.48 | 0.60 | 0.74 | 0.92 | 1.15 | 1.43 | 1.77 | 2.22 | 2.74 | 3.40 | 4.23 |
| Others | 0.83 | 1.03 | 1.28 | 1.59 | 1.97 | 2.43 | 3.03 | 3.74 | 4.65 | 5.74 | 7.12 |
Microbiome Therapeutics Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 2.15 | 2.66 | 3.31 | 4.10 | 5.09 | 6.33 | 7.89 | 9.79 | 12.15 | 15.14 | 18.76 |
| Rectal | 0.69 | 0.87 | 1.09 | 1.35 | 1.67 | 2.06 | 2.56 | 3.17 | 3.94 | 4.88 | 6.12 |
| Other | 0.62 | 0.77 | 0.95 | 1.19 | 1.49 | 1.86 | 2.29 | 2.86 | 3.56 | 4.41 | 5.47 |
Microbiome Therapeutics Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals/Clinics | 1.18 | 1.46 | 1.82 | 2.26 | 2.81 | 3.49 | 4.34 | 5.41 | 6.70 | 8.32 | 10.35 |
| Pharma/Biotech | 1.52 | 1.90 | 2.35 | 2.92 | 3.61 | 4.49 | 5.57 | 6.92 | 8.60 | 10.71 | 13.28 |
| Research/Academic | 0.55 | 0.69 | 0.86 | 1.06 | 1.33 | 1.65 | 2.05 | 2.54 | 3.17 | 3.91 | 4.86 |
| Others | 0.21 | 0.26 | 0.32 | 0.40 | 0.50 | 0.62 | 0.77 | 0.95 | 1.19 | 1.48 | 1.84 |
Microbiome Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.45 | 1.80 | 2.25 | 2.79 | 3.47 | 4.34 | 5.40 | 6.72 | 8.37 | 10.44 | 12.97 |
| Europe | 1.04 | 1.30 | 1.60 | 1.99 | 2.47 | 3.04 | 3.77 | 4.68 | 5.82 | 7.20 | 8.88 |
| Asia Pacific | 0.76 | 0.95 | 1.17 | 1.46 | 1.81 | 2.25 | 2.80 | 3.47 | 4.29 | 5.33 | 6.66 |
| Latin America | 0.10 | 0.13 | 0.16 | 0.20 | 0.25 | 0.31 | 0.38 | 0.47 | 0.59 | 0.73 | 0.91 |
| Middle East & Africa | 0.10 | 0.13 | 0.16 | 0.20 | 0.25 | 0.31 | 0.38 | 0.47 | 0.59 | 0.73 | 0.91 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
